TFEB Mediates Immune Evasion and Resistance to mTOR Inhibition of Renal Cell Carcinoma via Induction of PD-L1

Zhang, C; Duan, YQ; Xia, MH; Dong, YT; Chen, YF; Zheng, L; Chai, SS; Zhang, Q; Wei, ZP; Liu, N; Wang, J; Sun, CY; Tang, ZH; Cheng, X; Wu, J; Wang, GP; Zheng, F; Laurence, A; Li, B; Yang, XP

Yang, XP (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China.

CLINICAL CANCER RESEARCH, 2019; 25 (22): 6827

Abstract

Purpose: Despite the FDA approval of mTOR inhibitors (mTORi) for the treatment of renal cell carcinoma (RCC), the benefits are relatively modest and t......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索